Screener
SG&A at other companies
Other financials
Where this comes from
Reported directly by Core Scientific, Inc. in its filing.
Tagged under the XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense.
The source filing: Core Scientific, Inc.’s 10-Q, filed July 28, 2026.
- Filed
- Jul 28, 2026, 7:08 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001839341-26-000014
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Impairment of property, plant and equipment | — | — | 266,488 | — |
| Loss on contract termination | 41,948 | — | 41,948 | — |
| Colocation organizational and site startup costs | 27,039 | 11,655 | 35,704 | 23,322 |
| Selling, general and administrative | 49,389 | 45,285 | 94,568 | 78,175 |
| Operating loss | (78,468) | (26,284) | (388,890) | (73,322) |
| Non-operating expenses (income), net: | ||||
| Loss on debt extinguishment | 5,435 | 1,377 | 5,435 | 1,377 |
| Interest expense (income), net | 23,833 | (1,185) | 28,690 | (3,372) |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Core Scientific, Inc.'s SG&A?
- Core Scientific, Inc. (CORZ) reported SG&A of $49.39M in Q2 2026.
- How has Core Scientific, Inc.'s SG&A changed year-over-year?
- Core Scientific, Inc.'s SG&A decreased by 13.3% year-over-year, from $56.94M to $49.39M.
- What is the long-term trend for Core Scientific, Inc.'s SG&A?
- Over 2 years (2023 to 2025), Core Scientific, Inc.'s SG&A has grown at a 24.1% compound annual growth rate (CAGR), from $108.11M to $166.41M.
- What does SG&A mean?
- Combined selling expenses (sales force, marketing, distribution) and general & administrative costs (management, legal, accounting, facilities) — the broadest opex category.
Ask your AI about Core Scientific, Inc.'s sg&a.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude